Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bebo Health's Enterprise Value is €163.77 Mil.
Bebo Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €1.62 Mil. Therefore, Bebo Health's EV-to-EBIT ratio for today is 101.03.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bebo Health's Enterprise Value is €163.77 Mil.
Bebo Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €5.12 Mil. Therefore, Bebo Health's EV-to-EBITDA ratio for today is 32.01.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bebo Health's Enterprise Value is €163.77 Mil.
Bebo Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €25.25 Mil. Therefore, Bebo Health's EV-to-Revenue ratio for today is 6.49.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Bebo Health's Enterprise Value is €163.77 Mil.
Bebo Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil. Therefore, Bebo Health's EV-to-FCF ratio for today is .
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Bebo Health (XPAR:MLBBO) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Bebo Health's current Enterprise Value is €163.77 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Bebo Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €1.62 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Bebo Health's current Enterprise Value is €163.77 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Bebo Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €5.12 Mil.
Bebo Health's current Enterprise Value is €163.77 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Bebo Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €25.25 Mil.
Bebo Health's current Enterprise Value is €163.77 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Bebo Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.
Bebo Health's current Enterprise Value is €163.77 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Bebo Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health Enterprise Value Related Terms
Bebo Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Bebo Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: Enterprise Value Comparison
For the Specialty Retail subindustry, Bebo Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health Enterprise Value vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Bebo Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Bebo Health's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health (XPAR:MLBBO) has a Enterprise Value of €163.77 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bebo Health and its competitors.
Is Bebo Health's Enterprise Value too high?
Bebo Health's current Enterprise Value is €163.77 Mil. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Enterprise Value compare to CASY and WSM?
Bebo Health's Enterprise Value of €163.77 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Retail - Cyclical company?
A good Enterprise Value depends on the Retail - Cyclical industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bebo Health and its competitors. Bebo Health's current Enterprise Value is €163.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current Enterprise Value is €163.77 Mil. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Enterprise Value is €163.77 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
Enterprise Value: €163.77 Mil
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 